Replies to post #4329 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Welcome to the board, Vin.

>[To Pre_Clinical]: It is too soon to dismiss Factor VII and you have no idea how well any second generation Factor VII will pan out.<

Quite true. In fact, one of the second-generation FVIIa programs touted by Pre_Clinical — MAXY-Seven from Maxygen — is not doing so well. Roche recently pulled the plug on this program and returned all rights to MAXY (#msg-17854630, #msg-19911920). Regards, Dew

[jessellivermore]

Hear hear.....amen brother